Page last updated: 2024-08-18

pyridostigmine bromide and Muscle Weakness

pyridostigmine bromide has been researched along with Muscle Weakness in 35 studies

Research

Studies (35)

Timeframe	Studies, this research(%)	All Research%
pre-1990	3 (8.57)	18.7374
1990's	2 (5.71)	18.2507
2000's	10 (28.57)	29.6817
2010's	13 (37.14)	24.3611
2020's	7 (20.00)	2.80

Authors

Authors	Studies
Remijn-Nelissen, L; Tannemaat, MR; Verschuuren, JJGM	1
Dunkhase-Heinl, U; Fagerberg, CR; Illum, N; Larsen, MJ; Laulund, LW; Lester, EB; Schrøder, HD	1
Kaplan, F; Topal, E	1
Harrison, A; Mudhar, O; Rampal, M; Yoo, J	1
Işık, K; Odabaşı, Z; Özenç, B	1
de Meel, RHP; Tannemaat, MR; Verschuuren, JJGM	1
Barros-Angueira, F; Eirís-Puñal, J; Fuentes-Pita, P; Gómez-Lado, C; López-Vázquez, A; Pardo, J; Pérez-Gay, L; Quintas-Rey, R	1
Chaudhry, C; Kaur, A; Mehta, A	1
Ramakrishnan, P; Siddiqui, S	1
Ghazanfari, N; Morsch, M; Phillips, WD; Reddel, SW; Toyka, KV	1
Cui, X; Du, Y; Fang, H; Gao, F; Li, Q; Liu, P; Yang, J; Zhang, J; Zhang, Q; Zhang, Y; Zhao, X	1
Feuer, WJ; Gratton, SM; Herro, AM; Lam, BL	1
Cowan, MJ; Horn, BN; Strober, J	1
Cattaneo, L; Cucurachi, L; Gemignani, F; Pavesi, G	1
Khadilkar, SV; Mansukhani, KA; Singh, RK; Sternberg, D; Urtizberea, JA	1
Blobner, M; Fink, H; Frick, CG; Helming, M; Martyn, JA	1
Korucuk, M; Sener, U; Uludag, IF; Zorlu, Y	1
Costa, R; Scheer, BV; Valero-Burgos, E	1
Rehman, HU	1
Alaama, T; Basharat, P; Nicolle, MW	1
Auff, E; Cetin, H; Hilger, E; Jung, R; Paul, A; Wuschitz, B; Zach, H; Zimprich, F	1
Clarke, NF; Dowling, JJ; Feldman, EL; Gibbs, EM; Oates, EC; Rose, K; Webster, R	1
Gnanamuthu, C; Joseph, TP; Shankar, A; Solomon, T	1
Aarli, JA; Gilhus, NE; Myking, A; Romi, F; Varhaug, JE	1
FURTADO, D	1
BOUDIN, G; GOULON, M; HAMBURGER, J; LAPRESLE, J; LHERMITTE, F; PEQUIGNOT, H	1
Bowditch, AP; Griffiths, GD; Pearce, PC; Scott, EA; Stevens, D	1
Brighina, F; D'Amelio, M; Daniele, O; Di Benedetto, N; Fierro, B; Ragonese, P; Savettieri, G	1
Doi, S; Hamada, T; Honma, S; Takei, A; Yaguchi, H; Yamashita, I	1
Bhagavati, S; Chari, G; Maccabee, PJ	1
Bril, V; Cooper, JD; Ilse, WK; Kojic, J	1
Diószeghy, P; Répássy, G; Tóth, A; Tóth, L	1
Kaiser, KS	1
Abou-Donia, MB; Abu-Qare, AW	1

Other Studies

35 other study(ies) available for pyridostigmine bromide and Muscle Weakness

Article	Year
The effectiveness and side effects of pyridostigmine in the treatment of myasthenia gravis: a cross-sectional study. Neuromuscular disorders : NMD, 2022, Volume: 32, Issue:10 Topics: Cross-Sectional Studies; Humans; Muscle Weakness; Myasthenia Gravis; Pyridostigmine Bromide	2022
Ryanodine receptor 1 related myasthenia like myopathy responsive to pyridostigmine. European journal of medical genetics, 2023, Volume: 66, Issue:3 Topics: Adolescent; Humans; Male; Muscle Weakness; Muscle, Skeletal; Muscular Diseases; Mutation; Phenotype; Pyridostigmine Bromide; Ryanodine Receptor Calcium Release Channel	2023
Successful desensitization protocol for pyridostigmine in a 12 year old patient with myasthenia gravis. The Turkish journal of pediatrics, 2023, Volume: 65, Issue:2 Topics: Acetylcholinesterase; Child; Cholinesterase Inhibitors; Female; Humans; Hypersensitivity; Muscle Weakness; Myasthenia Gravis; Pyridostigmine Bromide	2023
Diplopia in a patient presenting with "blurred vision": a case report. Journal of medical case reports, 2023, Sep-08, Volume: 17, Issue:1 Topics: Diplopia; Female; Humans; Muscle Weakness; Myasthenia Gravis; Prednisone; Pyridostigmine Bromide; Vision Disorders	2023
Isolated Bilateral Triceps Weakness in Myasthenia Gravis. Acta neurologica Taiwanica, 2024, Jun-30, Volume: 33(2) Topics: Blepharoptosis; Humans; Male; Middle Aged; Muscle Weakness; Muscle, Skeletal; Myasthenia Gravis; Pyridostigmine Bromide	2024
Heterogeneity and shifts in distribution of muscle weakness in myasthenia gravis. Neuromuscular disorders : NMD, 2019, Volume: 29, Issue:9 Topics: Adult; Age of Onset; Aged; Blepharoptosis; Cholinesterase Inhibitors; Cohort Studies; Deglutition Disorders; Diplopia; Disease Progression; Dysarthria; Extremities; Facial Muscles; Female; Glucocorticoids; Humans; Immunosuppressive Agents; Male; Mastication; Masticatory Muscles; Middle Aged; Muscle Weakness; Muscle, Skeletal; Myasthenia Gravis; Neck Muscles; Oculomotor Muscles; Pharyngeal Muscles; Phenotype; Prednisone; Prospective Studies; Pyridostigmine Bromide; Respiratory Muscles	2019
Clinical and neurophysiological response to ephedrine in a patient affected with slow-channel congenital myasthenic syndrome. Revista de neurologia, 2020, Sep-16, Volume: 71, Issue:6 Topics: Alleles; Child; Electromyography; Ephedrine; Female; Heterozygote; Humans; Muscle Weakness; Mutation, Missense; Myasthenic Syndromes, Congenital; Phenotype; Point Mutation; Pyridostigmine Bromide; Receptors, Nicotinic	2020
Fluctuating weakness: clue in the eyes! BMJ case reports, 2020, Dec-28, Volume: 13, Issue:12 Topics: Blepharoptosis; Child; Cholinesterase Inhibitors; Eye Movements; Female; Humans; India; Muscle Weakness; Pyridostigmine Bromide; Treatment Outcome	2020
Myasthenia Gravis as a Cause of Failed Extubation Diagnosed by Diaphragmatic Ultrasound. Journal of the College of Physicians and Surgeons--Pakistan : JCPSP, 2019, Volume: 29, Issue:5 Topics: Aged, 80 and over; Airway Extubation; Anesthesia, General; Cholangiopancreatography, Endoscopic Retrograde; Cholangitis; Diaphragm; Female; Humans; Immunoglobulins, Intravenous; Intensive Care Units; Muscle Weakness; Myasthenia Gravis; Pyridostigmine Bromide; Respiration, Artificial; Respiratory Insufficiency; Ultrasonography	2019
Pyridostigmine but not 3,4-diaminopyridine exacerbates ACh receptor loss and myasthenia induced in mice by muscle-specific kinase autoantibody. The Journal of physiology, 2013, May-15, Volume: 591, Issue:10 Topics: 4-Aminopyridine; Amifampridine; Animals; Autoantibodies; Cholinesterase Inhibitors; Evoked Potentials; Female; Humans; Immunoglobulin G; Mice; Mice, Inbred C57BL; Muscle Weakness; Muscle, Skeletal; Myasthenia Gravis, Autoimmune, Experimental; Neuromuscular Junction; Pyridostigmine Bromide; Receptor Protein-Tyrosine Kinases; Receptors, Cholinergic	2013
Clinical features of patients with Myasthenia gravis from the Henan province, China. Muscle & nerve, 2016, Volume: 53, Issue:5 Topics: Adolescent; Adrenal Cortex Hormones; Adult; Age Distribution; Age of Onset; Aged; Aged, 80 and over; Autoantibodies; Azathioprine; Child; Child, Preschool; China; Cholinesterase Inhibitors; Cohort Studies; Female; Humans; Immunoglobulins, Intravenous; Immunologic Factors; Immunosuppressive Agents; Infant; Male; Middle Aged; Muscle Weakness; Myasthenia Gravis; Pyridostigmine Bromide; Receptors, Cholinergic; Retrospective Studies; Sex Distribution; Thymectomy; Thymus Gland; Young Adult	2016
Cigarette Smoking and Activities of Daily Living in Ocular Myasthenia Gravis. Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society, 2016, Volume: 36, Issue:1 Topics: Activities of Daily Living; Adult; Aged; Aged, 80 and over; Autoantibodies; Cholinesterase Inhibitors; Cross-Sectional Studies; Female; Glucocorticoids; Humans; Male; Middle Aged; Muscle Weakness; Myasthenia Gravis; Oculomotor Muscles; Prednisone; Prospective Studies; Pyridostigmine Bromide; Receptors, Cholinergic; Smoking; Smoking Cessation; Young Adult	2016
Allogeneic hematopoietic cell transplantation for refractory myasthenia gravis. Archives of neurology, 2009, Volume: 66, Issue:5 Topics: Adolescent; Autoantibodies; Cholinesterase Inhibitors; Hematopoietic Stem Cell Transplantation; Humans; Immunoglobulins, Intravenous; Immunologic Factors; Male; Muscle Weakness; Myasthenia Gravis; Ophthalmoplegia; Plasmapheresis; Pyridostigmine Bromide; Receptors, Cholinergic; Synaptic Transmission; Treatment Failure; Treatment Outcome	2009
Late onset generalized myasthenia gravis presenting with facial weakness and bulbar signs without extraocular muscle involvement. Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2009, Volume: 30, Issue:4 Topics: Action Potentials; Aged; Anti-Inflammatory Agents; Cholinesterase Inhibitors; Deglutition Disorders; Dysphonia; Electric Stimulation; Facial Muscles; Facial Nerve; Humans; Immunoglobulins, Intravenous; Magnetic Resonance Imaging; Male; Muscle Weakness; Myasthenia Gravis; Prednisone; Pyridostigmine Bromide	2009
Relief from episodic weakness with pyridostigmine in paramyotonia congenita: a family study. Muscle & nerve, 2010, Volume: 41, Issue:1 Topics: Adult; Cholinesterase Inhibitors; Electromyography; Female; Follow-Up Studies; Humans; Muscle Weakness; Myotonic Disorders; Pedigree; Pyridostigmine Bromide	2010
Continuous administration of pyridostigmine improves immobilization-induced neuromuscular weakness. Critical care medicine, 2010, Volume: 38, Issue:3 Topics: Animals; Atracurium; Cholinesterase Inhibitors; Disease Models, Animal; Hindlimb; Immobilization; Infusion Pumps; Infusions, Subcutaneous; Male; Muscle Contraction; Muscle Strength; Muscle Weakness; Muscular Atrophy; Neuromuscular Junction; Neuromuscular Nondepolarizing Agents; Pyridostigmine Bromide; Rats; Rats, Sprague-Dawley; Receptors, Cholinergic	2010
Myasthenia gravis as a cause of head drop in Parkinson disease. The neurologist, 2011, Volume: 17, Issue:3 Topics: Aged; Cholinesterase Inhibitors; Electromyography; Head; Humans; Immunoglobulins, Intravenous; Male; Muscle Weakness; Myasthenia Gravis; Neck Muscles; Parkinson Disease; Pyridostigmine Bromide	2011
Myasthenia gravis and endurance exercise. American journal of physical medicine & rehabilitation, 2012, Volume: 91, Issue:8 Topics: Athletes; Cholinesterase Inhibitors; Deglutition Disorders; Fatigue; Glucocorticoids; Humans; Male; Middle Aged; Muscle Cramp; Muscle Weakness; Myasthenia Gravis; Nystagmus, Pathologic; Physical Endurance; Prednisone; Pyridostigmine Bromide; Respiration Disorders; Rest; Risk Factors; Running; Speech Intelligibility	2012
A 90 year old man with difficulty swallowing and proximal muscle weakness. BMJ (Clinical research ed.), 2012, Apr-04, Volume: 344 Topics: Aged, 80 and over; Cholinesterase Inhibitors; Deglutition Disorders; Diagnosis, Differential; Fatal Outcome; Glucocorticoids; Hand; Humans; Lambert-Eaton Myasthenic Syndrome; Lower Extremity; Male; Muscle Weakness; Myasthenia Gravis; Prednisolone; Pyridostigmine Bromide	2012
Unusual case of recurrent falls: myasthenia gravis in an elderly patient. Canadian family physician Medecin de famille canadien, 2012, Volume: 58, Issue:11 Topics: Accidental Falls; Aged, 80 and over; Antibodies; Blepharoptosis; Cholinesterase Inhibitors; Dysarthria; Electrodiagnosis; Facial Muscles; Female; Glucocorticoids; Humans; Immunoglobulins, Intravenous; Muscle Weakness; Myasthenia Gravis; Neurologic Examination; Prednisone; Pyridostigmine Bromide; Receptors, Cholinergic; Recurrence	2012
The effect of early prednisolone treatment on the generalization rate in ocular myasthenia gravis. European journal of neurology, 2013, Volume: 20, Issue:4 Topics: Adult; Age of Onset; Aged; Anti-Inflammatory Agents; Autoantibodies; Blepharoptosis; Cholinesterase Inhibitors; Disease Progression; Eye Diseases; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Male; Middle Aged; Muscle Weakness; Myasthenia Gravis; Oculomotor Muscles; Prednisolone; Pyridostigmine Bromide; Receptors, Cholinergic; Retrospective Studies; Risk Assessment	2013
Neuromuscular junction abnormalities in DNM2-related centronuclear myopathy. Journal of molecular medicine (Berlin, Germany), 2013, Volume: 91, Issue:6 Topics: Adult; Animals; Child; Cholinesterase Inhibitors; Disease Models, Animal; Dynamin II; Female; Humans; Male; Motor Activity; Muscle Weakness; Muscle, Skeletal; Myopathies, Structural, Congenital; Neuromuscular Junction; Pyridostigmine Bromide; Young Adult; Zebrafish	2013
Autosomal recessive limb girdle myasthenia in two sisters. Neurology India, 2002, Volume: 50, Issue:4 Topics: Adolescent; Adult; Cholinesterase Inhibitors; Drug Therapy, Combination; Edrophonium; Female; Genes, Recessive; Humans; Muscle Weakness; Myasthenia Gravis; Pyridostigmine Bromide	2002
Thymectomy in nonthymoma early-onset myasthenia gravis in correlation with disease severity and muscle autoantibodies. European neurology, 2003, Volume: 49, Issue:4 Topics: Acetylcholine; Adrenal Cortex Hormones; Adult; Age of Onset; Autoantibodies; Cholinesterase Inhibitors; Connectin; Female; Follow-Up Studies; Humans; Male; Muscle Proteins; Muscle Weakness; Muscles; Myasthenia Gravis; Plasmapheresis; Protein Kinases; Pyridostigmine Bromide; Remission Induction; Retrospective Studies; Ryanodine Receptor Calcium Release Channel; Severity of Illness Index; Thymectomy; Thymus Gland; Treatment Outcome	2003
[A new drug, pyridostigmine, in therapy of myasthenia]. Jornal do medico, 1954, Apr-17, Volume: 23, Issue:586 Topics: Muscle Weakness; Myasthenia Gravis; Parasympathomimetics; Pyridostigmine Bromide	1954
[New data on the treatment of myasthenia by O.M.P.A. and pyridostigmine]. La Presse medicale, 1954, Dec-18, Volume: 62, Issue:85 Topics: Diphosphates; Disease; Muscle Weakness; Muscles; Muscular Diseases; Parasympathomimetics; Pyridostigmine Bromide	1954
[HOW TO TREAT MYASTHENIA]. La Presse medicale, 1964, Oct-10, Volume: 72 Topics: Ambenonium Chloride; Ephedrine; Humans; Muscle Weakness; Myasthenia Gravis; Neostigmine; Physostigmine; Prognosis; Pyridostigmine Bromide; Respiratory Insufficiency; Spironolactone; Surgical Procedures, Operative; Thymus Neoplasms	1964
Multiple vaccine and pyridostigmine interactions: effects on cognition, muscle function and health outcomes in marmosets. Pharmacology, biochemistry, and behavior, 2006, Volume: 84, Issue:2 Topics: Acetylcholinesterase; Alanine Transaminase; Alkaline Phosphatase; Animals; Body Weight; Callithrix; Cognition; Creatinine; Discrimination, Psychological; Female; Isocitrate Dehydrogenase; Male; Muscle Weakness; Muscles; Persian Gulf Syndrome; Pyridostigmine Bromide; Urea; Vaccines	2006
Dropped head as an unusual presenting sign of myasthenia gravis. Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2007, Volume: 28, Issue:2 Topics: Cervical Vertebrae; Cholinesterase Inhibitors; Female; Head; Humans; Magnetic Resonance Imaging; Middle Aged; Muscle Weakness; Myasthenia Gravis; Neck Muscles; Pyridostigmine Bromide; Recovery of Function; Treatment Outcome	2007
Dropped head sign as the only symptom of myasthenia gravis. Internal medicine (Tokyo, Japan), 2007, Volume: 46, Issue:11 Topics: Cholinesterase Inhibitors; Edrophonium; Electromyography; Head; Humans; Male; Middle Aged; Muscle Weakness; Myasthenia Gravis; Posture; Pyridostigmine Bromide; Quality of Life	2007
Is cerebral involvement an occasional feature of muscle-specific kinase antibody-positive syndrome? European journal of neurology, 2007, Volume: 14, Issue:8 Topics: Adult; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Autoantibodies; Brain; Cholinesterase Inhibitors; Electroencephalography; Epilepsy; Female; Humans; Immunoglobulins, Intravenous; Memory Disorders; Muscle Weakness; Muscle, Skeletal; Myasthenia Gravis; Mycophenolic Acid; Prednisone; Pyridostigmine Bromide; Receptor Protein-Tyrosine Kinases; Receptors, Cholinergic; Treatment Outcome	2007
Long-term clinical outcome after transcervical thymectomy for myasthenia gravis. The Annals of thoracic surgery, 1998, Volume: 65, Issue:6 Topics: Adolescent; Adult; Cholinesterase Inhibitors; Female; Follow-Up Studies; Humans; Longitudinal Studies; Male; Middle Aged; Muscle Contraction; Muscle Weakness; Myasthenia Gravis; Odds Ratio; Palliative Care; Pyridostigmine Bromide; Remission Induction; Thymectomy; Treatment Outcome	1998
Electronystagmographic analysis of optokinetic nystagmus for the evaluation of ocular symptoms in myasthenia gravis. Acta oto-laryngologica, 1999, Volume: 119, Issue:6 Topics: Adult; Cholinesterase Inhibitors; Electronystagmography; Humans; Middle Aged; Muscle Weakness; Myasthenia Gravis; Nystagmus, Optokinetic; Oculomotor Muscles; Pyridostigmine Bromide	1999
Pyridostigmine bromide intake during the Persian Gulf War is not associated with postwar handgrip strength. Military medicine, 2000, Volume: 165, Issue:3 Topics: Adult; Case-Control Studies; Cholinesterase Inhibitors; Drug Synergism; Female; Hand Strength; Humans; Insecticides; Linear Models; Male; Middle East; Muscle Weakness; Naval Medicine; Occupational Exposure; Pyridostigmine Bromide; Surveys and Questionnaires; United States; Veterans; Warfare	2000
Determination of depleted uranium, pyridostigmine bromide and its metabolite in plasma and urine following combined administration in rats. Journal of pharmaceutical and biomedical analysis, 2001, Volume: 26, Issue:2 Topics: Administration, Oral; Animals; Cholinesterase Inhibitors; Chromatography, High Pressure Liquid; Injections, Intradermal; Muscle Weakness; Organometallic Compounds; Pyridostigmine Bromide; Rats; Rats, Sprague-Dawley; Reproducibility of Results; Spectrophotometry; Tremor; Uranium	2001